Interleukin 4 promotes survival of lethally irradiated mice in the absence of hematopoietic efficacy

Radiation Research

Volumn 152, Issue 6, 1999, Pages 629-636

  Van Der Meeren, Anne ^a   Gaugler, Marie Hélène ^a   Mouthon, Marc André ^a   Squiban, Claire ^a   Gourmelon, Patrick ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT 60; CYTOKINE; RECOMBINANT INTERLEUKIN 4; RECOMBINANT THROMBOPOIETIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLOOD CELL COUNT; BONE MARROW; CONTROLLED STUDY; GAMMA RADIATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IMMUNOMODULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; SPLEEN; SURVIVAL RATE;

EID: 0032785898     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3580258     Document Type: Article

References (46)

1. F. G. Schuening, F. R. Appelbaum, H. J. Deeg, M. Sullivan-Pepe, T. C. Graham, R. Hackman, K. M. Zsebo and R. Storb, Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation. Blood 81, 20-26 (1993).
2. S. Tanikawa, M. Nose, Y. Aoki, K. Tsuneoka, M. Shikita and N. Nara, Effects of recombinant granulocyte colony-stimulating factor on the hematologic recovery and survival of irradiated mice. Blood 76, 445-449 (1990).
3. M. L. Patchen, T. J. MacVittie and L. M. Souza, Postirradiation treatment with granulocyte colony-stimulating factor and preirradiation WR-2721 administration synergize to enhance hemopoietic reconstitution and increase survival. Int. J. Radiat. Oncol. Biol. Phys. 22, 773-779 (1992).
4. M-A. Mouthon, A. Van der Meeren, M-H. Gaugler, T. P. Visser, C. Squiban, P. Gourmelon and G. Wagemaker, Thrombopoietin promotes hematopoietic recovery and survival after high-dose whole body irradiation. Int. J. Radiat. Oncol. Biol. Phys. 43, 867-875 (1999).
5. R. Neta, J. J. Oppenheim and S. D. Douches, Interdependence of the radioprotective effects of human recombinant interleukin 1α, tumor necrosis factor α, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor. J. Immunol. 140, 108-111 (1988).
6. R. Neta, S. M. Stiefel, F. Finkelman, S. Herrmann and N. Ali, IL-12 protects bone marrow from and sensitizes intestinal tract to ionizing radiation. J. Immunol. 153, 4230-4237 (1994).
7. I. Ding, T. Wu, H. Marsubara, J. Magae, M. Shou, J. Cook and P. Okunieff, Acidic fibroblast growth factor (FGF1) increases survival and haematopoietic recovery in total body irradiated C3H/HeNCr mice. Cytokine 9, 59-65 (1997).
8. M. C. Galmiche, C. A. Vogel, A. B. Delaloye, P. M. Schmidt, F. Healy, J. P. Mach and F. Buchegger, Combined effects of interleukin-3 and interleukin-11 on hematopoiesis in irradiated mice. Exp. Hematol. 24, 1298-1306 (1996).
9. L. Milas and W. R. Hanson, Eicosanoids and radiation. Eur. J. Cancer 31A, 1580-1585 (1995).
10. T. A. Girinsky, M. Pallardy, E. Comoy, T. Benassi, R. Roger, G. Ganem, J. M. Cosset, G. Socie and H. Magdelenat, Peripheral blood corticotropin-releasing factor, adrenocorticotropic hormone and cytokine (interleukin beta, interleukin 6, tumor necrosis factor alpha) levels after high- and low-dose total-body irradiation in humans. Radiat. Res. 139, 360-363 (1994).
11. I. Nishiguchi, Y. Furuta, N. Hunter, D. Murray and L. Milas, Radio-protection of hematopoietic tissues in mice by indomethacin. Radiat. Res. 122, 188-192 (1990).
12. M. Pospisil, J. Netikova and A. Kozubik, Enhancement of hemopoietic recovery by indomethacin after sublethal whole-body gamma irradiation. Acta Radiol. Oncol. 3, 195-198 (1986).
13. M. Howard, J. Farrar, M. Hilfiker, B. Johnson, B. Takatsu and W. E. Paul, Identification of a B cell growth factor distinct from interleukin 2. J. Exp. Med. 155, 914-923 (1982).
14. W. E. Paul, Interleukin-4: A prototypic immunoregulatory lymphokine. Blood 77, 1859-1870 (1991).
15. M. A. Brown and J. Hural, Functions of IL-4 and control of its expression. Crit. Rev. Immunol. 17, 1-32 (1997).
16. T. Siitonen, A. Zheng, E. R. Savolainen and P. Koistinen, The effect of interleukin-4 with or without mast cell growth factor on peripheral blood granulocyte-macrophage colony-forming cells in healthy controls and in myeloproliferative disorders. Ann. Hematol. 70, 203-207 (1995).
17. F. W. Jacobsen, J. R. Keller, F. W. Ruscetti, O. P. Veiby and S. E. W. Jacobsen, Direct synergistic effects of IL-4 and IL-11 on proliferation of primitive hematopoietic progenitor cells. Exp. Hematol. 23, 990-995 (1995).
18. D. Rennick, J. Jackson, G. Yang, J. Wideman, F. Lee and S. Hudak, Interleukin-6 interacts with interleukin-4 and other hematopoietic growth factors to selectively enhance the growth of megakaryocytic, erythroid, myeloid, and multipotential progenitor cells. Blood 73, 1828-1835 (1989).
19. C. Peschel, I. Green and W. E. Paul, Interleukin-4 induces a substance in bone marrow stromal cells that reversibly inhibits factor-dependent and factor-independent cell proliferation. Blood 73, 1130-1141 (1989).
20. A. Ferrajoli, M. Talpaz, N. G. Ordonez, E. R. Stanley, C. Hirsch-Ginsberg, T. F. Zipf, M. Wetzler, R. Kurzrock and Z. Estrov, Interleukin 4 alters human bone marrow stroma and modulates its interaction with hematopoietic progenitors. Stem Cells 12, 638-649 (1994).
21. W. A. Wertheim, S. L. Kunkel, T. J. Standiford, M. D. Burdick, F. S. Becker, C. A. Wilke, A. R. Gilbert and R. M. Stricter, Regulation of neutrophil-derived IL-8: The role of prostaglandin E2, dexamethasone, and IL-4. J. Immunol. 151, 2166-2175 (1993).
22. A. A. Te Velde, R. J. F. Huijbens, K. Heije, J. E. De Vries and C. G. Figdor, Interleukin-4 (IL-4) inhibits secretion of IL-1β, tumor necrosis factor α, and IL-6 by human monocytes. Blood 76, 1392-1397 (1990).
23. T. J. Standiford, R. M. Stricter, S. W. Chensue, J. Westwick, K. Kasahara and S. L. Kunkel, IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J. Immunol. 145, 1435-1439 (1990).
24. H. Niiro, T. Otsuka, K. Izuhara, K. Yamaoka, K. Oshima, T. Tanaba, S. Hara, Y. Nemoto, Y. Tanaka and Y. Niho, Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils. Blood 89, 1621-1628 (1997).
25. A. Maru and S. K. Jackson, Opposite effects of interleukin-4 and interleukin-10 on nitric oxide production in murine macrophages. Mediat. Inflamm. 5, 110-112 (1996).
26. S. L. Abramson and J. I. Gallin, IL-4 inhibits superoxide production by human mononuclear phagocytes. J. Immunol. 144, 625-630 (1990).
27. A. C. De Beaux, J. P. Maingay, J. A. Ross, K. C. H. Fearon and D. C. Carter, Interleukin-4 and interleukin-10 increase endotoxin-stimulated human umbilical vein endothelial cell interleukin-8 release. J. Interferon Cytokine Res. 15, 441-445 (1995).
28. R. Renkonen, P. Manila, M. L. Majuri, T. Paavonen and O. Silvennoinen, IL-4 decreases IFN-γ induced endothelial ICAM-1 expression by a transcriptional mechanism. Scand. J. Immunol. 35, 525-530 (1992).
29. A. Van der Meeren, C. Squiban, P. Gourmelon, H. Lafont and M-H. Gaugler, Differential regulation by IL-4 and IL-10 of radiation-induced IL-6 and IL-8 production and ICAM-1 expression by human endothelial cells. Cytokine, in press.
30. S. C. Gautam, N. F. Chikkala and T. A. Hamilton, Anti-inflammatory action of IL-4 Negative regulation of contact sensitivity to trinitrochlorobenzene. J. Immunol. 148, 1411-1415 (1992).
31. J. B. Allen, H. L. Wong, G. L. Costa, M. J. Bienkowski and S. M. Walh, Suppression of monocyte function and differential regulation of IL-1 and IL-1Ra by IL-4 contribute to resolution of experimental arthritis. J. Immunol. 151, 4344-4351 (1993).
32. R. Gundel, D. Lindell, P. Harris, M. Fournel, G. Jesmok and M. E. Gerritsen, IL-4 induced leucocyte trafficking in cynomolgus monkeys: Correlation with expression with expression of adhesion molecules and chemokine generation. Clin. Exp. Allergy 26, 719-729 (1996).
33. K. J. Neelis, T. P. Visser, W. Dimjati, G. R. Thomas, P. J. Fielder, D. Bloedow, D. L. Eaton and G. Wagemaker, A single dose of thrombopoietin early after myelosuppressive total body irradiation prevents pancytopenia by promoting short-term multilineage repopulating cells at the expense of a more immature cell population. Blood 92, 1586-1597 (1998).
34. H. Inoue, Y. Koezuka, N. Nishi, M. Osawa, K. Motoki, E. Kobayashi, K. Kabaya, M. Obuchi, H. Fukushima and K. J. Mori, Alpha-galactosylceramide (AGL-517) treatment protects mice from lethal irradiation. Exp. Hematol. 25, 935-944 (1997).
35. M. B. Atkins, G. Vachino, H. J. Tilg, D. D. Karp, N. J. Robert, K. Kappler and J. W. Mier, Phase I evaluation of thrice-daily intravenous bolus interleukin-4 in patients with refractory malignancy. J. Clin. Oncol. 10, 1802-1809 (1992).
36. P. Chomarat, M. E. Rybak and J. Banchereau, Interleukin-4. In The Cytokine Handbook, 3rd ed. (A. Thompson, Ed.), pp. 133-174. Academic Press, London, 1998.
37. C. S. Potten, A comprehensive study of the radiobiological response of the murine (BDF1) small intestine. Int. J. Radiat. Biol. 58, 925-973 (1990).
38. V. Esposito, C. Linard, C. Maubert, J. Aigueperse and P. Gourmelon, Modulation of gut substance P after whole-body irradiation. A new pathological feature. Dig. Dis. Sci. 41, 2070-2077 (1996).
39. A. François, J. Aigueperse, P. Gourmelon, W. K. MacNaughton and N. M. Griffiths, Exposure to ionizing radiation modifies neurally-evoked electrolyte transport and some inflammatory responses in rat colon in vitro. Int. J. Radiat. Biol. 73, 93-101 (1998).
40. I. Brook and T. B. Elliott, Quinolone therapy in the prevention of mortality after irradiation. Radiat. Res. 128, 100-103 (1991).
41. P. Everest, J. Allen, A. Papakonstantinopoulou, P. Mastroeni, M. Roberts and G. Dougan, Salmonella typhimurium infections in mice deficient in interleukin-4 production. J. Immunol. 159, 1820-1827 (1997).
42. + lymphocytes in gut-associated lymphoid tissue during resolution of infection. J. Immunol. 161, 1891-1900 (1998).
43. A. Keane-Myers, C. R. Maliszewski, F. D. Finkelman and S. P. Nickell, Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice. J. Immunol. 156, 2488-2494 (1996).
44. C. A. Redlich, X. Gao, S. Rockwell, M. Kelley and J. A. Elias, IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. J. Immunol. 157, 1705-1710 (1996).
45. H. S. Reinhold, L. F. Fajardo and J. W. Hopewell, The vascular system. Adv. Radiat. Biol. 14, 177-226 (1990).
46. M. P. Law, Radiation-induced vascular injury and it relation to late effects in normal tissues. Adv. Radiat. Biol. 9, 38-71 (1981).